Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

 

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

2016-01-23 07:38:52| Biotech - Topix.net

Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha Injection, the first proprotein convertase subtilisin/kexin type 9 inhibitor to be approved in Japan. Repatha is a human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol , or "bad" cholesterol, from the blood.

Tags: japan approval injection announces

Category:Biotechnology and Pharmaceuticals

Latest from this category	All news
»	05.07 Hurricane Beryl Graphics 05.07 Hurricane Beryl Public Advisory Number 25A 05.07 Summary for Hurricane Beryl (AT2/AL022024) 05.07 Amazon at 30: What next for 'The Everything Company'? 05.07 Atlantic Tropical Weather Outlook 05.07 Could the 'flying piano' help transform air cargo? 05.07 Eastern North Pacific Tropical Weather Outlook 04.07 Hurricane Beryl Graphics More »